Table 2. A selection of differentially up-regulated genes of the vitelline tissue normalised to the whole female control.
*Systematic name | Gene name | Fold change | Contig | Protein description |
Q2_P25336 | Smp_164320 | 12.67 | C810082.1 | hypothetical protein |
Q2_P41174 | Smp_041540 | 4.02 | JAP07007.C | hormone receptor 4 (dHR4), putative |
Q2_P39884 | Smp_056350 | 3.33 | JAP08870.C | mitotic spindle assembly checkpoint protein mad2- |
Q2_P40473 | Smp_170990 | 3.05 | JAP07382.S | vinculin, putative |
Q2_P39851 | Smp_174820 | 2.85 | JAP08581.C | serine/threonine kinase, putative |
Q2_P36026 | Smp_173320 | 2.58 | C915812.1 | tubulin tyrosine ligase-related |
Q2_P37617 | Smp_169380 | 2.53 | C918667.1 | protein-tyrosine phosphatase, putative |
Q2_P36808 | Smp_162900 | 2.37 | C917244.1 | tyrosine-protein kinase pr2, putative |
Q2_P38755 | Smp_148680 | 2.28 | JAP01788.S | DNA double-strand break repair rad50 ATPase, |
Q2_P27568 | Smp_076950.2 | 2.24 | C900263.1 | solute carrier family 33 (acetyl-CoA transporter) |
Q2_P26890 | Smp_008580 | 2.23 | C812627.1 | sugar transporter, putative |
Q2_P31891 | Smp_124110 | 2.13 | C907823.1 | smad nuclear interacting protein, putative |
Q2_P35951 | Smp_137080 | 2.11 | C915708.1 | multidrug resistance protein 1, 2, 3 |
Q2_P33700 | Smp_158400 | 2.04 | C911301.1 | receptor protein tyrosine phosphatase r (pcptp1), |
*The systematic naming of probes follows [14].